| BCBS Oklahoma Medical Policies | Erythropoiesis-Stimulating Agents (ESAs) | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Esketamine Nasal Spray | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Esophageal pH Monitoring | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Etranacogene dezaparvovec-drlb | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Facet Joint and Sacroiliac Joint Denervation | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Facet Joint Injections | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Faricimab-svoa | 2026-01-01 |
| BCBS Oklahoma Medical Policies | FDA - Drugs, Biologicals, Cellular and Gene Therapies | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Fetal Surgery for Prenatally Diagnosed Malformations | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Focal Treatments for Prostate Cancer | 2026-01-01 |